Prostate Cancer
Conference Coverage
AVAHO Mtg: Germline Testing Key for Vets With High-Risk PC
Attendees learn that about 10% of patients could benefit from testing
News
New Screening Protocol May Improve Prostate Cancer Detection
A new trial assesses a screening intervention that aims to reduce unnecessary diagnoses of prostate cancer but still catch relevant cancers and...
Conference Coverage
How Long Should Active Surveillance Last?
New data “suggest that meticulous follow-up is needed over a longer time” than previous studies have shown.
Latest News
Meat Linked to Higher Erectile Dysfunction Risk
NYU urologist discusses impact of a plant-based diet on heart health, prostate cancer, and sexual health.
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
Case Reports
EBER-Negative, Double-Hit High-Grade B-Cell Lymphoma Responding to Methotrexate Discontinuation
The authors present a case of stage IV double-hit B-cell lymphoma with the presence of MYC and BCL6 gene rearrangements in an older veteran with...
News
New Trials in Prostate Cancer: Could Your Patient Benefit?
Two new trials for patients with metastatic castration-resistant prostate cancer that involve remaining on therapy until disease progression...
News
Prostate Cancer Tsunami Coming, Experts Caution
Expert suggests approaches for enabling earlier diagnosis of prostate cancer in men in low- to middle-income countries.
Latest News
New Guidelines: Start PSA Screening Earlier in Black Men
Multidisciplinary panel suggests lowering the screening age to 40-45 for PSA testing in Black men.